Micronutrients and Depression: The Role of Zinc, Magnesium, and B Vitamins

By Kyle Roth, FNP-BC, APRN, MSN, MHA | Roth Family Medicine and Mental Health | Pocatello, Idaho

The relationship between nutrition and mental health is one of the most rapidly developing areas in psychiatry. For decades, the dominant model of depression focused almost exclusively on neurotransmitter imbalances — too little serotonin, not enough dopamine. But this model is incomplete. Depression is a complex, multifactorial condition, and for many patients, nutritional deficiencies play a significant and underappreciated role.

The emerging field of nutritional psychiatry is documenting what clinicians practicing integrative and functional medicine have observed for years: that deficiencies in specific micronutrients can cause or worsen depression, and that correcting those deficiencies can produce meaningful improvements in mood — sometimes dramatically so.

The brain is the most metabolically active organ in the body. It requires a continuous supply of nutrients to synthesize neurotransmitters, maintain neuronal membranes, produce energy, and regulate inflammation. When key micronutrients are deficient, these processes are impaired — and the result can be depression, anxiety, cognitive dysfunction, and fatigue.

Several factors make micronutrient deficiency surprisingly common, even in developed countries:

• Nutrient-depleted soil — modern agricultural practices have reduced the micronutrient content of many foods
• Processed food consumption — the standard American diet is calorie-dense but micronutrient-poor
• Gut dysfunction — conditions like leaky gut, dysbiosis, and celiac disease impair nutrient absorption
• Medication effects — many common medications (PPIs, metformin, oral contraceptives) deplete specific nutrients
• Increased demand — chronic stress, illness, and intense exercise increase micronutrient requirements
• Genetic variants — MTHFR and other genetic polymorphisms impair the metabolism of specific nutrients

Zinc is one of the most important — and most commonly deficient — micronutrients in relation to depression.

Multiple meta-analyses have found that people with depression have significantly lower serum zinc levels than non-depressed controls. A 2013 meta-analysis of 17 studies found that zinc levels were significantly lower in depressed patients, with the deficit more pronounced in patients with more severe depression.

Randomized controlled trials have found that zinc supplementation — both as monotherapy and as augmentation to antidepressants — produces significant reductions in depressive symptoms. A 2013 RCT found that zinc supplementation significantly enhanced the antidepressant effect of imipramine in patients with major depression.

Zinc plays multiple roles relevant to mental health:

• NMDA receptor modulation — zinc is a natural NMDA receptor antagonist, similar in mechanism to ketamine. This may explain part of its antidepressant effect.
• BDNF production — zinc is required for the synthesis and release of Brain-Derived Neurotrophic Factor, which supports neuroplasticity and mood regulation
• Neuroinflammation — zinc has anti-inflammatory properties and modulates microglial activation
• Neurotransmitter synthesis — zinc is a cofactor in the synthesis of serotonin and other neurotransmitters

• Vegetarian and vegan diets (plant-based zinc is less bioavailable)
• Alcohol use disorder
• Digestive disorders (Crohn's, celiac)
• Older age
• Pregnancy and breastfeeding

Serum zinc is the most practical assessment, though it doesn't fully capture total body zinc status. Supplementation with zinc gluconate or zinc picolinate (15–30mg/day) is generally well-tolerated. Note that high-dose zinc supplementation can deplete copper — a copper supplement or copper-containing multivitamin should be taken alongside zinc if supplementing long-term.

Magnesium is involved in over 300 enzymatic reactions in the body — and deficiency is extraordinarily common. Estimates suggest that 50–80% of Americans don't meet the recommended daily intake for magnesium.

The relationship between magnesium and depression is well-documented. A 2009 cross-sectional study of over 8,000 adults found that low magnesium intake was significantly associated with depression, particularly in younger adults. Multiple RCTs have found that magnesium supplementation reduces depressive symptoms, with one 2017 trial finding that magnesium was as effective as imipramine for mild to moderate depression.

Magnesium's antidepressant mechanisms include:

• NMDA receptor regulation — like zinc, magnesium is a natural NMDA receptor antagonist. Magnesium deficiency leads to NMDA receptor hyperactivation, which is associated with depression and anxiety.
• HPA axis modulation — magnesium regulates the stress response; deficiency leads to HPA axis hyperreactivity and elevated cortisol
• Serotonin synthesis — magnesium is a cofactor in the conversion of tryptophan to serotonin
• Neuroinflammation — magnesium has anti-inflammatory effects and reduces microglial activation
• Sleep quality — magnesium promotes GABA activity and improves sleep quality, which has downstream mood benefits

Not all magnesium supplements are equal. The most bioavailable and well-tolerated forms for mental health include:

• Magnesium glycinate — highly bioavailable, gentle on the GI tract, good for anxiety and sleep
• Magnesium threonate — crosses the blood-brain barrier particularly well; may have specific cognitive benefits
• Magnesium malate — good for energy and fatigue

Magnesium oxide (the most common form in cheap supplements) has poor bioavailability and is primarily useful as a laxative.

The B vitamin family plays essential roles in neurotransmitter synthesis, methylation, and energy production — all of which are critical for mental health.

Folate and B12 are perhaps the most studied B vitamins in relation to depression. Both are essential for the methylation cycle — a biochemical pathway that produces SAMe (S-adenosylmethionine), the body's primary methyl donor. SAMe is required for the synthesis of serotonin, dopamine, and norepinephrine.

Folate deficiency is associated with depression, and low folate levels predict poor response to antidepressants. L-methylfolate (the active form of folate) is FDA-approved as an adjunct to antidepressants for patients with major depression.

B12 deficiency produces neuropsychiatric symptoms including depression, cognitive impairment, and fatigue. B12 deficiency is common in older adults, vegetarians and vegans, and people taking metformin or PPIs.

MTHFR variants — genetic polymorphisms in the MTHFR gene affect the conversion of dietary folate to its active form. People with MTHFR variants may need methylated forms of folate (L-methylfolate) and B12 (methylcobalamin) rather than the synthetic forms found in most supplements.

B6 is a cofactor in the synthesis of serotonin, dopamine, GABA, and norepinephrine. Deficiency is associated with depression and anxiety. B6 deficiency is more common in people taking oral contraceptives, which deplete B6.

Thiamine is essential for glucose metabolism in the brain. Deficiency — most commonly seen in alcohol use disorder — produces neuropsychiatric symptoms including depression, anxiety, and cognitive impairment. Subclinical thiamine deficiency may be more common than recognized.

Iron deficiency is the most common nutritional deficiency worldwide. Iron is required for the synthesis of dopamine and serotonin, and iron deficiency anemia produces fatigue, cognitive impairment, and mood changes that closely mimic depression. Iron deficiency without anemia (low ferritin with normal hemoglobin) can also cause significant symptoms.

While technically not micronutrients, omega-3 fatty acids (EPA and DHA) deserve mention. Multiple meta-analyses have found that omega-3 supplementation — particularly EPA — has significant antidepressant effects. The mechanism involves anti-inflammatory effects, modulation of neurotransmitter signaling, and support of neuronal membrane function.

Vitamin D deficiency is endemic in Idaho (see our dedicated article on vitamin D and depression). Low vitamin D is consistently associated with depression, and supplementation has antidepressant effects in deficient individuals.

At Roth Family Medicine and Mental Health, we take a comprehensive approach to nutritional assessment in patients with depression and other mood disorders. Our evaluation typically includes:

• Serum zinc and copper
• Red blood cell magnesium (more accurate than serum magnesium)
• Folate and B12 levels
• Homocysteine (a functional marker of methylation status)
• Iron studies including ferritin
• Vitamin D (25-OH)
• Omega-3 index (optional but informative)
• MTHFR genetic testing (when indicated)

Addressing nutritional deficiencies is rarely sufficient as a standalone treatment for moderate to severe depression — but it can be a meaningful piece of a comprehensive treatment plan, and for some patients with primarily nutritional contributors to their depression, it can be transformative.

If you're interested in a functional medicine approach to your mental health, we'd welcome the opportunity to work with you.

Kyle Roth, FNP-BC, APRN, MSN, MHA is a board-certified family nurse practitioner at Roth Family Medicine and Mental Health in Pocatello, Idaho, specializing in treatment-resistant depression, ketamine therapy, TMS, hormone optimization, and integrative mental health care. To schedule a consultation, visit ZocDoc or call (208) 904-4705.